BMO Capital analyst Andrew Kaip downgraded Newmont Goldcorp to Market Perform from Outperform after resuming coverage of the name. He raised his price target for the shares to $45 from $42. While both the acquisition of Goldcorp and the formation of the Nevada joint venture have been accretive events, near-term investor uncertainty regarding the Goldcorp transaction, compounded by recent events at Musselwhite and Penasquito, are likely to "temper investor interest" until Newmont Goldcorp is able to demonstrate value, Kaip tells investors in a research note. As such, the analyst remains cautious until Newmont "demonstrates progress."